Viking Therapeutics, Inc. (1VT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:05AM CEST. Market open.
| Previous close | 74.06 |
| Open | 73.50 |
| Bid | 72.12 x 290000 |
| Ask | 73.08 x 280000 |
| Day's range | 71.04 - 73.50 |
| 52-week range | 8.62 - 91.50 |
| Volume | |
| Avg. volume | 2,205 |
| Market cap | 7.833B |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.86 |
| Earnings date | 24 July 2024 - 29 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 20.10 |
Insider MonkeyViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking […]
- Thomson Reuters StreetEvents
Q1 2024 Viking Therapeutics Inc Earnings Call
Q1 2024 Viking Therapeutics Inc Earnings Call
- GuruFocus.com
Viking Therapeutics Inc (VKTX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Explore the pivotal financial outcomes and strategic directions from Viking Therapeutics' first quarter of 2024.
© 2024 Yahoo. All rights reserved.